The purpose of this initiative is to stimulate basic research, discovery, and early translational research to enable and accelerate the generation of highly efficacious pre-erythrocytic stage malaria vaccines, including sporozoite-based vaccines . Cross-fertilization and collaboration among investigators from malaria vaccine research and other basic research areas such as parasite biology, parasite genomics, pathogenesis, and host immunology are highly encouraged. The goal is to generate one or more promising vaccine candidates against human malaria that exhibit performance superior to currently available sporozoite-based vaccines and are suitable for further downstream process development and future clinical evaluation.
Deadlines:
RFA-AI-19-059 Expiration Date January 18, 2020
The application budget may not exceed $750K in direct costs per year and should reflect the actual needs of the project.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
